E. Bohula

发表

Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician.

S. van Diepen, P. Eckman, J. Katz, 2019, Circulation.

The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript*

E. Southern, E. Bohula, Muhammad Sohail, 2003, The Journal of Biological Chemistry.

Advanced Respiratory Support in the Contemporary Cardiac ICU

D. Morrow, S. van Diepen, E. Keeley, 2020, Critical care explorations.

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

R. Giugliano, E. Braunwald, C. Cannon, 2017, Journal of the American Heart Association.

Title : Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

R. Califf, B. Lewis, R. Giugliano, 2022 .

Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50

Marc P. Bonaca, E. Braunwald, H. White, 2015, Circulation.

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial

Marc P. Bonaca, Lawrence A Leiter, A. Keech, 2019, Circulation.

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Marc P. Bonaca, Lawrence A Leiter, A. Keech, 2018, The New England journal of medicine.

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.

R. Giugliano, E. Braunwald, C. Cannon, 2016, European heart journal.

Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry.

C. Granger, D. Morrow, L. Newby, 2019, Circulation. Heart failure.

Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS

Marc P. Bonaca, D. Morrow, B. Scirica, 2019, Clinical chemistry and laboratory medicine.

Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase

Y. Shiloh, N. Smorodinsky, E. Bohula, 2001, Oncogene.

Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".

R. Giugliano, E. Braunwald, C. Cannon, 2016, Circulation.

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes Vytorin Efficacy International Trial)

R. Giugliano, E. Braunwald, C. Cannon, 2018, Circulation.

De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.

D. Morrow, S. Sinha, C. Fordyce, 2021, Journal of cardiac failure.

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT

R. Giugliano, E. Braunwald, C. Cannon, 2017 .

The Intersection between Heart Failure and Critical Care Cardiology: An International Perspective on Structure, Staffing, and Design Considerations.

A. Mebazaa, S. Sinha, S. Leonardi, 2022, Journal of cardiac failure.

Editor’s Choice-Prospective registry of cardiac critical illness in a modern tertiary care Cardiac Intensive Care Unit

D. Morrow, D. Berg, E. Bohula, 2018, European heart journal. Acute cardiovascular care.

Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P‐TIMI 50 trial

Marc P. Bonaca, M. Sabatine, D. Morrow, 2022, Clinical cardiology.

High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial.

Marc P. Bonaca, E. Braunwald, H. White, 2017, Clinical chemistry.

Inflammatory and Cholesterol Risk in the FOURIER Trial

Lawrence A Leiter, A. Keech, R. Giugliano, 2018, Circulation.

Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.

D. Morrow, S. Sinha, D. Berg, 2021, Journal of the American College of Cardiology.

Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.

D. Morrow, S. Sinha, D. Berg, 2020, JAMA cardiology.

COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies

E. Bohula, V. Nauffal, Hasan K. Siddiqi, 2020 .

Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.

R. Califf, R. Giugliano, E. Braunwald, 2019, Journal of the American College of Cardiology.

Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry

D. Morrow, J. D. de Lemos, E. Bohula, 2022, Journal of the American Heart Association.

Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients

D. Morrow, S. Sinha, S. van Diepen, 2022, JACC advances.

Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock after Acute Myocardial Infarction.

Deepak L. Bhatt, R. Blankstein, M. Carli, 2022, Journal of cardiac failure.

Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system

Eric A. Meyerowitz, D. Morrow, P. Natarajan, 2020, EClinicalMedicine.

Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system

Eric A. Meyerowitz, D. Morrow, P. Natarajan, 2020, EClinicalMedicine.

Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".

R. Giugliano, E. Braunwald, C. Cannon, 2018, Circulation.

Left ventricle unloading strategies in ECMO: A single‐center experience

Steven P. Keller, D. Morrow, H. Mallidi, 2020, Journal of cardiac surgery.

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Rajnish K. Prasad, M. Sabatine, D. Morrow, 2022, Circulation.

Management of Non-ST-Elevation Myocardial Infarction: The Bright Gleam of Progress, but Much Work Remains.

E. Antman, E. Bohula, 2016, JAMA.

Reply: Ezetimibe, Risk Stratification, and Secondary Prevention.

R. Giugliano, E. Braunwald, C. Cannon, 2017, Journal of the American College of Cardiology.

Epidemiology and causes of cardiogenic shock

D. Morrow, D. Berg, E. Bohula, 2021, Current opinion in critical care.

P-56 HUMAN MELANOMA CELLS EXPRESSING V600E B-RAF ARE SUSCEPTIBLE TO IGF1R

A. H. Yeh, E. Bohula, V. Macaulay, 2006 .

Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network

D. Morrow, S. Sinha, D. Berg, 2022, Journal of Cardiac Failure.

EPIDEMIOLOGY OF SHOCK IN CONTEMPORARY CARDIAC INTENSIVE CARE UNITS: DATA FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY

D. Morrow, D. Berg, S. van Diepen, 2019, Journal of the American College of Cardiology.

Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN).

C. Granger, D. Morrow, L. Newby, 2022, Resuscitation.

COVID-19 for the Cardiologist

D. Morrow, E. Bohula, V. Nauffal, 2020, JACC: Basic to Translational Science.

A current review of COVID-19 for the cardiovascular specialist

D. Morrow, E. Bohula, Hasan K. Siddiqi, 2020, American Heart Journal.

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

E. Antman, R. Giugliano, E. Braunwald, 2015, Circulation.

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

E. Bohula, M. Playford, V. Macaulay, 2003, Anti-cancer drugs.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

R. Califf, B. Lewis, R. Giugliano, 2015, The New England journal of medicine.

Asynchronous Cell Cycle and Asymmetric Vacuolar Inheritance in True Hyphae of Candida albicans

D. Soll, D. Wessels, S. Kron, 2003, Eukaryotic Cell.

How does the TRS 2°P score relate to real-world patients?

Marc P. Bonaca, D. Atar, J. Ferrières, 2018, European heart journal. Cardiovascular pharmacotherapy.

The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry

D. Morrow, S. Sinha, D. Berg, 2021, Critical care medicine.

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

R. Collins, S. Cosgrove, P. Libby, 2017, The Lancet.

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

M. Ezekowitz, S. Connolly, S. Hohnloser, 2022, Circulation.

Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs

A. H. Yeh, E. Bohula, V. Macaulay, 2006, Oncogene.

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Marc P. Bonaca, B. Lewis, M. Sabatine, 2016, Circulation.

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

R. Giugliano, E. Braunwald, C. Cannon, 2017, Circulation.

Single-cell transcriptomics reveal hyperacute cytokine and immune checkpoint axis in patients with poor neurological outcomes after cardiac arrest

D. Morrow, J. Varon, Wenan Chen, 2022, bioRxiv.

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease

Deepak L. Bhatt, E. Braunwald, D. Morrow, 2017, Diabetes Care.

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.

R. Giugliano, E. Braunwald, C. Cannon, 2017, Journal of the American College of Cardiology.

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.

R. Giugliano, E. Braunwald, C. Cannon, 2016, Journal of the American College of Cardiology.

Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry

D. Morrow, D. Berg, P. Lawler, 2022, Circulation. Heart failure.

CLINICAL STAGING IN CARDIOGENIC SHOCK DISCRIMINATES SURVIVAL: DATA FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY

D. Morrow, P. Lawler, J. Katz, 2020 .

Epidemiology of Shock in Contemporary Cardiac Intensive Care Units: Data From the Critical Care Cardiology Trials Network Registry

D. Morrow, D. Berg, P. Lawler, 2019, Circulation. Cardiovascular quality and outcomes.

Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.

C. Granger, D. Morrow, P. Lawler, 2019, JAMA cardiology.

Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.

R. Califf, R. Giugliano, E. Braunwald, 2019, JAMA cardiology.

Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials

Deepak L. Bhatt, E. Antman, R. Giugliano, 2021, Circulation.

Cardiogenic shock due to causes other than acute myocardial infarction

D. Morrow, D. Berg, E. Bohula, 2021 .

Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients–Thrombolysis in Myocardial Infarction 61 (CAMELLIA‐TIMI 61) trial

A. Keech, M. Sabatine, B. Scirica, 2018, American heart journal.

Permanent Drug Discontinuation , and Study Retention in Clinical Trials Insights From the TIMI trials

Deepak L. Bhatt, E. Antman, R. Giugliano, 2021 .

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

Marc P. Bonaca, M. Pfeffer, R. Giugliano, 2022, European heart journal.

EPIDEMIOLOGY OF SHOCK AND ECMO

S. van Diepen, P. Eckman, J. Katz, 2019 .

Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT

R. Giugliano, E. Braunwald, C. Cannon, 2015, Circulation.

Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock

D. Morrow, B. Scirica, E. Bohula, 2016, European heart journal. Acute cardiovascular care.

Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association

C. Arslanian-Engoren, C. Fordyce, S. van Diepen, 2020, Circulation.

Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table

G. Hindricks, H. Diener, M. Endres, 2019, European journal of preventive cardiology.

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.

B. Scirica, Darren K Mcguire, S. Inzucchi, 2018, Lancet.

Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective

D. Morrow, S. Sinha, S. Leonardi, 2020, Journal of the American College of Cardiology.

Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19 : A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.

D. Morrow, J. D. de Lemos, R. Yeh, 2021, Circulation. Heart failure.

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Hong Wang, A. Keech, R. Giugliano, 2020, Stroke.

Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.

D. Morrow, S. van Diepen, J. Katz, 2020, American heart journal.

Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19

Amit R. Patel, T. Villines, R. Blankstein, 2020, Journal of the American College of Cardiology.

COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery

D. Morrow, S. Sinha, S. Leonardi, 2020, Journal of the American College of Cardiology.

Presentation and Outcomes of Patients With Preoperative Critical Illness Undergoing Cardiac Surgery

D. Morrow, C. Fordyce, D. Berg, 2023, JACC. Advances.

Critical Care Cardiology Trials Network (CCCTN): a cohort profile.

D. Morrow, L. Newby, S. Sinha, 2022, European heart journal. Quality of care & clinical outcomes.

Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus.

Deepak L. Bhatt, R. Giugliano, M. Sabatine, 2022, Journal of the American College of Cardiology.

Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit.

Rajnish K. Prasad, D. Morrow, C. Fordyce, 2023, JACC. Heart failure.

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

D. Morrow, J. D. de Lemos, E. Bohula, 2023, American Heart Journal.

CAN TRIAGE TO CARDIAC INTENSIVE CARE UNITS FOR ACUTE CORONARY SYNDROMES BE REFINED: DATA FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY

D. Morrow, J. Katz, E. Bohula, 2019, Journal of the American College of Cardiology.

The Road Not Yet Traveled: Distinction in Critical Care Cardiology through the Advanced Heart Failure and Transplant Cardiology Training Pathway.

J. Katz, E. Bohula, A. Carnicelli, 2021, Journal of cardiac failure.

How does the TRS 2 (cid:2) P score relate to real-world patients?

Marc P. Bonaca, D. Atar, J. Ferrières, 2018 .

How does the TRS 2 (cid:2) P score relate to real-world patients?

Marc P. Bonaca, D. Atar, J. Ferrières, 2018 .

Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P‐TIMI 50 trial

Marc P. Bonaca, M. Sabatine, D. Morrow, 2023, Clinical Cardiology.

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.

R. Giugliano, E. Braunwald, C. Cannon, 2016, Journal of the American College of Cardiology.

Abstract 17169: The Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

E. Antman, R. Giugliano, E. Braunwald, 2015 .

Variation in risk-adjusted Cardiac Intensive Care Unit (CICU) length of stay and the association with in-hospital mortality: an analysis from the Critical Care Cardiology Trials Network (CCCTN) registry

Rajnish K. Prasad, E. Bohula, Pablo A Sanchez, 2024, American Heart Journal.

Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial.

R. Giugliano, E. Bohula, M. Elliott-Davey, 2023, American heart journal.

Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry

Rajnish K. Prasad, E. Bohula, M. Kontos, 2024, Circulation. Cardiovascular quality and outcomes.